| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2019) |
Articles |
Adverse effects of statin therapy: real evidence |
(Rus)
|
| Vol 11, No 1 (2020) |
Original study articles |
Modern principles of atherogenic dyslipidemia management in special groups of patients |
(Rus)
|
| Vol 11, No 4 (2020) |
Editorial |
Rehabilitation after new coronavirus infection (COVID-19): principles and approaches |
(Rus)
|
| Vol 12, No 2 (2021) |
Consensus |
Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation |
(Rus)
|
| Vol 12, No 2 (2021) |
Reviews |
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities |
(Rus)
|
| Vol 12, No 4 (2021) |
Reviews |
Type 2 diabetes mellitus and chronic heart failure: new treatment strategies |
(Rus)
|
| Vol 13, No 1 (2022) |
Reviews |
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review |
(Rus)
|
| Vol 13, No 1 (2022) |
Reviews |
Current guidelines for β-adrenoblockers use in cardiovascular diseases: focus on metoprolol succinate CR/XL: A review |
(Rus)
|
| Vol 14, No 3 (2023) |
Original study articles |
Long-term effects of a home exercise program in patients with acute myocardial infarction and percutaneous coronary intervention: prospective observational study |
(Rus)
|
| Vol 15, No 4 (2024) |
Reviews |
Maintaining optimal physical activity of patients following cardiac rehabilitation |
(Rus)
|
| Vol 16, No 1 (2025) |
Consensus |
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
(Rus)
|
